Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-01-02

Clinical Trial Update: A Study Of Lidocaine Patch 5% Alone, Gabapentin Alone, And Lidocaine Patch 5% And Gabapentin In Combination For The Relief Of Pain In Patients With Diverse Peripheral Neuropathic Pain Conditions [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating lidocaine patch 5% alone, gabapentin alone, and combination for relief of peripheral neuropathic pain.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Gabapentin (Gabapentin)
  • Lidocaine patch 5% (Lidocaine)

Snippet

Sponsor: Endo Pharmaceuticals | Conditions: Postherpetic Neuralgia, Diabetic Neuropathy | Phase 4 | Status: COMPLETED